Breaking Down Canopy Growth Corp’s (TSX:WEED) Awful Q2 Results

Why Canopy Growth Corp (TSX:WEED)(NYSE:CGC) stock could be doomed after missing expectations in Q2 by a wide margin.

| More on:
Piggy bank next to a financial report

Image source: Getty Images.

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) saw its share price tank after releasing quarterly results this past week that showed sales falling well short of expectations. Posting a loss has not been that big of a deal for cannabis stocks thus far, but missing on sales could be disastrous for an industry that has long promised astronomical growth.

For the quarter, analysts were expecting the company to hit sales of around $60 million. Instead, Canopy Growth recorded just $23 million in sales, a year-over-year increase of 33%. It’s a catastrophic miss for a company that’s been the poster boy for the cannabis industry, and it could have investors second guessing the industry’s ambitious growth targets.

Not only did Canopy Growth miss on sales, but its financials were downright brutal.

Changes in fair value cripple the company’s gross margin

Investors might recall that in prior periods, Canopy Growth and other pot stocks getting a big benefit from changes in fair value where gross profits sometimes eclipsed sales, making them look a little funny. As expected, the pendulum finally swung back, and this quarter Canopy Growth incurred fair value losses totaling more than $40 million, pulling its gross profit into the red.

Shared-based compensation weighs down financials even further

Operating expenses totaled more than $180 million in Q2 and were nearly seven times the $27 million incurred a year ago. Share-based compensation was a big driver behind the increase, making up nearly $100 million of those expenses, compared to just $7 million in the prior year.

Also showing significant increases were general and administrative costs, which grew from $8 million to $37 million. Sales and marketing costs saw a similar increase, going from $7 million up to $39 million.

Last year, Canopy Growth came close to breaking even on its operations, but this year it was deep in the red with a loss of more than $214 million. Other expenses related to fair value saddled the company with an additional $111 million, which led to an overall net loss of $330 million for the quarter.

Is Canopy Growth falling behind its peers?

Earlier in the week we saw other big-name cannabis companies release their earnings, which showed much stronger results. Aurora Cannabis saw its top line more than double from the prior year, while Tilray Inc was able to grow its sales by 85%.

It’s likely that we’ll see Canopy Growth bounce back next quarter, especially with recreational sales playing a big role in those results, but other producers will also see a boost, which could be a warning sign that the company may be losing its position in the industry.

Should you consider buying the stock?

Canopy Growth was down big as a result of the disappointing earnings, and it’s not a stock that I would consider buying anytime soon. These results have likely created a lot of doubt as to whether the company will be able to achieve the growth needed to justify its high stock price. It’s a very risky investment today, and the stock could see a lot more bearish activity in the weeks and months to come.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Investing

Target. Stand out from the crowd
Investing

2 Canadian Stocks I’m Buying Lots of This Year

I’m looking to snatch up exciting Canadian stocks like VieMed Healthcare Inc. (TSX:VMD) throughout 2023.

Read more »

grow money, wealth build
Dividend Stocks

Got $3,000? 3 TSX Growth Stocks to Buy in January 2023

Top TSX growth stocks that look appealing for 2023.

Read more »

woman data analyze
Dividend Stocks

Need Passive Income? Turn $15,000 Into $851 Annually

This passive-income stock is already climbing higher, up 16% in the last three months! Yet it's still valuable, so you…

Read more »

Senior Man Sitting On Sofa At Home With Pet Labrador Dog
Dividend Stocks

Retirees: 3 Reliable Canadian Dividend Stocks to Buy Now for Passive Income

Top TSX dividend stocks now appear oversold.

Read more »

A red umbrella stands higher than a crowd of black umbrellas.
Investing

2 TSX Stocks Safer for Investing in a Recession

These consumer companies will likely beat the broader market averages amid a recession. These stocks offer stability, income, and consistent…

Read more »

Dividend Stocks

For $100 in Passive Income Each Month, Buy 1,500 Shares of This REIT

REITs such as Northwest Healthcare can enable investors create a passive-income stream as well as benefit from capital gains.

Read more »

A colourful firework display
Dividend Stocks

2 Canadian Growth Stocks (With Dividends) to Start 2023 With a Bang

Here are two of the best dividend-paying Canadian growth stocks you can invest in at the start of 2023 and…

Read more »

sale discount best price
Dividend Stocks

4 Insanely Cheap Canadian Stocks to Buy for Passive Income

The recent bear market has created some incredible bargains, especially for those looking for passive income. Here are four cheap…

Read more »